Ropes & Gray represented Avista Capital Partners in its acquisition of Taconic Biosciences, a provider of genetically engineered research models and related services, from H.I.G. Capital. Terms of the transaction were not disclosed. The announcement was made public on Nov. 1 in a press release.
Avista Capital, founded in 2005, is a leading New York-based private equity firm with over $8 billion invested in more than 40 growth-oriented healthcare businesses globally. Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services.
The Ropes & Gray team was led by private equity partner Bob Rivollier, and included senior private equity associate Sam Levitt, tax partner Benjamin Rogers, benefits partner Alexandra Alperovich, labor & employment partner Megan Bisk, finance partner Arek Maczka, real estate partner Peter Alpert, health care partner Devin Cohen, life sciences regulatory & compliance partners Kellie Combs and Lincoln Tsang, and litigation & enforcement partner Brendan Hanifin.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.